PeerVoice Heart & Lung Video

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 18m. Bisher sind 148 Folge(n) erschienen. Dies ist ein wöchentlich erscheinender Podcast.

Gesamtlänge aller Episoden: 2 days 6 hours 14 minutes

subscribe
share





Cardiovascular Risk and Prostate Cancer: Clinical Perspectives on ADT


Cardiovascular Risk and Prostate Cancer: Clinical Perspectives on ADT


share







   22m
 
 

Simplifying Fluid Therapy: Critical Care for the Critically Ill


Simplifying Fluid Therapy: Critical Care for the Critically Ill


share







   17m
 
 

SGLT2 Inhibition for HF: Evidence From Virtual Scientific Sessions 2020


SGLT2 Inhibition for HF: Evidence From Virtual Scientific Sessions 2020


share







   12m
 
 

A Look at Emerging SMA Outcomes: Highlights of WMS 2020


A Look at Emerging SMA Outcomes: Highlights of WMS 2020


share







   9m
 
 

Expert Advice on Uncontrolled Asthma: Should I Consider a Biologic for This Patient?


Expert Advice on Uncontrolled Asthma: Should I Consider a Biologic for This Patient?


share







 2020-11-17  24m
 
 

Modern Management of Chronic Kidney Disease: A Look to the Future


Modern Management of Chronic Kidney Disease: A Look to the Future


share







 2020-11-11  17m
 
 

Practice Challenges in Advanced EGFR-Mutant NSCLC: Clarifying First-Line Strategies


Practice Challenges in Advanced EGFR-Mutant NSCLC: Clarifying First-Line Strategies


share







 2020-11-09  26m
 
 

Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data


Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data


share







 2020-11-03  18m
 
 

Defining Control in Moderate-to-Severe Asthma: Where Are We Now and What Can We Do?


Defining Control in Moderate-to-Severe Asthma: Where Are We Now and What Can We Do?


share







 2020-10-30  18m
 
 

Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist


Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist


share







 2020-10-25  16m